ДИБАС Моххамед И. (US),ДОНЕЛЛО Джон Е. (US),ДЖИЛ Дэниел В. (US)
申请号：
RU2013124526/15
公开号：
RU2013124526A
申请日:
2011.11.10
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
1. A method for reducing intraocular pressure, which comprises topical administration of a therapeutically effective amount of a pharmaceutical composition comprising (S) (3- (1- (1H-imidazol-4-yl) ethyl) -2-methylphenyl) methanol or a salt thereof in the affected eye patient. 2. A method for reducing intraocular pressure, which comprises topical administration of a therapeutically effective amount of a pharmaceutical composition comprising (S) (3- (1- (1H-imidazol-4-yl) ethyl) -2-methylphenyl) methanol or a salt thereof in a patient’s affected eye in as a single dose, characterized in that the affected eye has a lower level of intraocular pressure compared with the baseline level of intraocular pressure for at least eight (8) hours. 3. A method according to claim 1, characterized in that the affected eye maintains a lower level of intraocular pressure, compared with the base level of intraocular pressure for at least ten (10) hours. A method according to claim 1, characterized in that the affected eye maintains a lower level of intraocular pressure, compared with the base level of intraocular pressure for at least twelve (12) hours. The method according to claim 1, characterized in that the composition contains from about 0.01% to about 5% by weight, (S) (3- (1- (1H-imidazol-4-yl) ethyl) -2-methylphenyl) methanol or its salt. 6. A method according to claim 1, characterized in that the composition contains from about 0.01% to about 2% by weight, (S) (3- (1- (1H-imidazol-4-yl) ethyl) -2-methylphenyl) methanol or its salt. 7. The method according to claim 1, characterized in that the composition contains from about 0.05% to about 1% by weight of (S) (3- (1- (1H-imidazol-4-yl) ethyl) -2-methylphenyl) methanol1. Способ снижения внутриглазного давления, который включает местное введение терапевтически эффективного количества фармацевтической композиции, содержащей (S)(3-(1-(1H-имидазол-4-ил)этил)-2-метилфенил)метанол или его соль в пораженный глаз пациента.2. Способ сниж
